Orchid Pharma Consolidated June 2023 Net Sales at Rs 182.92 crore, up 39.65% Y-o-Y

Orchid Pharma meets SEBI’s MPS norms after QIP brings promoter stake below 75%. Raised ₹400cr in QIP, public shareholding now 27.6%. Mutual Funds hold 9.78%, FPI 8.58%, rest held by domestic corporates & retail investors. Stock down 4% to ₹590 on NSE.

Orchid Pharma meets SEBI’s minimum public shareholding norms

Orchid Pharma seeks shareholders’ approval to purchase key raw material from Otsuka Chemicals, a material subsidiary, up to ₹250 crore for FY24. The transaction is material as it exceeds ₹1,000 crore or 10% of the company’s annual turnover. Otsuka also buys the end product from Orchid under a long-t…

Orchid Pharma seeks shareholder nod for Otsuka Chemicals

Orchid Pharma shares hit a life-time high after announcing tech transfer agreement with a multinational biotechnology firm for its ‘7ACA project’. 7-ACA is used for synthesis of cephalosporin antibiotics and intermediates. Stocks closed 4% higher than previous day’s closing price.

Orchid Pharma shares hit fresh high after signing tech transfer pact for cephalosporin intermediate

Orchid Pharma Ltd. enters tech transfer agreement for ‘7ACA project’ under PLI scheme. Subsidiary Orchid Bio Pharma approved to manufacture ‘7-ACA’ with 1,000 tonne capacity. MoU with overseas tech provider for in-licensing of 7ACA. Investment of ₹600 crore in new Jammu plant. 7ACA project to reduce…

Orchid Pharma inks tech transfer pact with biotechnology firm for 7ACA project

Chennai-based drug maker, Orchid Pharma, has signed a technology transfer agreement with a multinational biotechnology company, for its 7ACA project under the production linked incentive (PLI) scheme. The deal will enable Orchid Bio Pharma to manufacture “7-ACA” with a capacity of 1,000 tonnes p.a. …

Orchid Pharma enter tech transfer pact to make key cephalosporin intermediate

The Orchid Pharma board on Tuesday approved the issue and allotment of 99 lakh equity shares of face value ₹10 each to qualified institutional buyers at an issue price of ₹403.93 per equity share

Orchid Pharma raises ₹400-crore in QIP issue

Here are the top 10 stocks you need to keep on your radar in today's trading session. Take a look.

#topstocksinfocus #buzzingstocks #stockmarketupdates #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday   

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
                               👑 Check Out Top CNBC TV18 Playlist Videos: 

🔹CNBC TV18 Classic Interviews: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDmfXVg7XEQngsCY9RoS-fv

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDCcaVZ_82M9vhLo9lGJYzo

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH
🔹CNBC TV18 Newsreels: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCmABWWQRX4NqGLCtScwqex

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Startup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here

Key Stocks In Focus: HDFC Limited, HDFC Life, Ramco Cements, TCNS Clothing, BSE, Orchid Pharma

The stocks are rallying after Orchid Pharma launched a QIP to raise funds last week

Orchid Pharma shares hit 52-week high; locked in 5% upper circuit for the second day

What are the top stocks in trending and why you should keep a close eye on these stocks. Listen in more for the analysis and events behind stocks in focus. SBI Card Stocks, Orchid Pharma Stocks, Indigo | Top Stocks In Trending and recommended by Swati Hotkar In Today's Market Fatafat
#nifty #nifty50 #banknifty #niftypredictions #niftytoday #indices
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3

Subscribe Now To Our Network Channels :-
Times Now  : http://goo.gl/U9ibPb
The NewsHour Debate : http://goo.gl/LfNgFF

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

SBI Card Stocks, Orchid Pharma Stocks, Indigo | Top Stocks In Trending In Today's Market Fatafat

Sources have told CNBC-TV18 that the base size for the issue is approximately Rs 300 crore, with an option to upsize up to Rs 400 crore

Orchid Pharma locked in upper circuit, QIP floor price set at Rs 425

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Orchid Pharma Limited, formerly Orchid Chemicals & Pharmaceuticals Limited, is a pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bulk actives, formulations and nutraceuticals.